Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

Point of Care: Innovations of the Future

23 Oct 2013 - 24 Oct 2013 - London, UK

Bookmark and Share

Join SMi's highly successful 10th annual Point of Care: Innovations of the Future conference promising to be a must see event!

SMi’s highly respected and eagerly anticipated 10th Annual Point of Care: Innovations of the Future conference comes to London for what promises to be a highly thought provoking and thrilling event. Join a plethora of highly respected speakers as they discuss topics ranging from the analysis of how the future of Point of Care testing will look and change over the next decade to the different strategies medical trusts are putting in place to increase the use of Point of Care testing within the patient care setting. Identify potential gaps in the market for new technologies and learn how to successfully implement these in a highly competitive market place.

This year’s Point of Care: Innovations of the Future conference will focus on technologies aimed at treating infectious diseases, with a focus on the rapid identification and ‘on the spot’ diagnosis of infectious diseases such as HIV and TB. This year’s event will take a look at what strategies different healthcare trusts are implementing to increase the usage of Point of Care testing and diagnosis at the site of the patient.


Identify key industry trends and market opportunities

Discover new technological applications and the latest advances in device technology

Learn how to overcome potential barriers to commercialisation of a new technology

Gain an insight into the future of POC technologies

Understand the benefits of non-invasive patient testing and how new profiling technologies lead to a better personalised treatment approach


Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, University of Edinburgh

Trevor Lewis, CEO, Medical Device Consultancy

Phil Lefebvre, Senior Manager, Business Development, Abbott Laboratories

Penny Wilson, Innovation Platform Leader, Technology Strategy

Roger Peck, Technical Officer, PATH

Tony Gibson, Scientific Director, North East Pathology Network Coordinator

David Huckle, Chief Executive, Adams Business Associates

Maurice O’Kane, Consultant Chemical Pathologist /Director for Research and Development, Western Health and Social Care Trust

Mohammad Al-Ubaydli, CEO, Patients Know Best

Kavita Oberoi, Founder and Managing Director, Oberoi Consulting

Gillian Hall, POCT Coordinator, Royal Brompton and Harefield NHS Foundation Trust

Per Simonsson, Professor of Clinical Chemistry, University Hospital MAS

Nigel Sansom, Senior Manager, Celaris Biosystems

Jose Manuel Costa, Associate Professor, University of Oviedo

Brian Winn, Partner, NHS Institute for Innovation and Improvement

John Rippeth, Principle Consultant, PA Consulting

Contact: Darryl Moxon, Phone: +44 20 7827 6066, Email:

For Sponsorship opportunities contact Alia Malick on +44 (0)20 7827 6168 or email

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos